What AI says about Seamless Therapeutics

Seamless Therapeutics uses programmable recombinase technology to perform large, precise DNA edits anywhere in the human genome without introducing additional mutations. The company is developing a pipeline of disease-modifying gene editing therapies to address the genetic causes of severe diseases across a broad range of indications.